If you're in pharma R&D or regulatory affairs, this ICMR move is significant

If you're in pharma R&D or regulatory affairs, this ICMR move is significant.

Deploying top scientists to CDSCO signals a push for faster, more robust drug approvals. Expect heightened scientific scrutiny on trial data and methodology. This strengthens India's regulatory backbone, but also means your submissions need to be impeccable. Prepare for a more rigorous, science-backed review process. https://pharma.economictimes.indiatimes.com/news/policy-and-regulations/with-union-budget-in-rear-view-cdsco-gets-top-icmr-scientists-to-help-fast-track-drug-approval-timelines/127862955